Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

DH may remove access restrictions on Viagra generic

Clinical Government is considering removing restrictions on generic erectile dysfunction drug sildenafil, which has been available since Viagra came off patent in June 2013

Patients could soon have "unrestricted access" to a generic version of Viagra, if the Department of Health (DH) goes ahead with plans to make the drug available on NHS prescription.


The DH was considering removing restrictions on generic erectile dysfunction drug sildenafil, which has been available since Viagra came off patent in June 2013, it said in a consultation published last week (January 23).


The generic is 93 per cent cheaper than branded Viagra and the DH predicted that the expiry of Viagra's patent could save the NHS £38 million a year under current prescribing levels. As cost is no longer the main barrier to accessing treatment, the DH has decided that the drug should benefit a "wider spectrum of patients".


Even if demand for the drug tripled after  restrictions were removed, the NHS would still be able to afford it, the DH said

More on Viagra

Lloyds erectile dysfunction ad prompts ASA investigation

Sex? Not on the NHS

Update module 1579: Erectile dysfunction

The DH said it expected demand for sildenafil to increase if restrictions were removed. But it added that even if demand for the drug tripled, the NHS would still be able to afford it.


Current restrictions on prescribing the drug meant that some men seeking erectile dysfunction treatment due to severe distress had to be assessed by specialist services rather than their GP. The proposed changes would transfer many of these patients over to primary care, which would be an additional burden for GPs but would be more convenient for patients and save the NHS money, the DH said.


The DH would develop prescribing guidance to ensure prescribers and commissioners did not face "unmanageable demands" from people seeking sildenafil for recreational purposes, it said.


It would continue to restrict the supply of other erectile dysfunction treatments such as tadalafil, vardenafil and Viagra.


The consultation will run until March 21.



Will this change improve patient care?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016762

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel